Skip Content
You are currently on the new version of our website. Access the old version .

Antibodies, Volume 12, Issue 4

2023 December - 23 articles

Cover Story: Lyme disease is a tick-borne disease caused by spirochetes belonging to the Borrelia burgdorferi sensu lato complex. The disease is characterized by a varied course; therefore, the basis for diagnosis is laboratory methods. Currently, a two-tiered serological test is recommended, using an ELISA as a screening test and a Western blot as a confirmatory test. This approach was introduced due to the relatively high number of false-positive results obtained when using an ELISA alone. However, even this approach has not entirely solved the problem of false-positive results caused by cross-reactive antibodies. Many highly immunogenic B. burgdorferi s.l. proteins are recognized nonspecifically by antibodies directed against other pathogens. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (23)

  • Article
  • Open Access
9 Citations
8,532 Views
17 Pages

Heterogeneity in Disulfide Bond Reduction in IgG1 Antibodies Is Governed by Solvent Accessibility of the Cysteines

  • Ramakrishnan Natesan,
  • Andrew B. Dykstra,
  • Akash Banerjee and
  • Neeraj J. Agrawal

13 December 2023

We studied unpaired cysteine levels and disulfide bond susceptibility in four different γ-immunoglobulin antibodies using liquid chromatography–mass spectrometry. Our choice of differential alkylating agents ensures that the differential...

  • Article
  • Open Access
3,118 Views
12 Pages

Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Siberian Populations

  • Olga N. Shaprova,
  • Daniil V. Shanshin,
  • Evgeniia A. Kolosova,
  • Sophia S. Borisevich,
  • Artem A. Soroka,
  • Iuliia A. Merkuleva,
  • Artem O. Nikitin,
  • Ekaterina A. Volosnikova,
  • Nikita D. Ushkalenko and
  • Tatiana N. Ilyicheva
  • + 4 authors

9 December 2023

In December 2019, a new coronavirus, SARS-CoV-2, was found to in Wuhan, China. Cases of infection were subsequently detected in other countries in a short period of time, resulting in the declaration of the COVID-19 pandemic by the World Health Organ...

  • Review
  • Open Access
8 Citations
5,324 Views
17 Pages

8 December 2023

Neurodegenerative diseases (NDDs) affect millions of people worldwide. They develop due to the pathological accumulation and aggregation of various misfolded proteins, axonal and synaptic loss and dysfunction, inflammation, cytoskeletal abnormalities...

  • Article
  • Open Access
4 Citations
2,815 Views
10 Pages

Neutralization of Different Variants of SARS-CoV-2 by a F(ab′)2 Preparation from Sera of Horses Immunized with the Viral Receptor Binding Domain

  • Mariajosé Rodriguez-Nuñez,
  • Mariana del Valle Cepeda,
  • Carlos Bello,
  • Miguel Angel Lopez,
  • Yoneira Sulbaran,
  • Carmen Luisa Loureiro,
  • Ferdinando Liprandi,
  • Rossana Celeste Jaspe,
  • Flor Helene Pujol and
  • Héctor Rafael Rangel

7 December 2023

The Receptor Binding Domain (RBD) of SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is the functional region of the viral Spike protein (S), which is involved in cell attachment to target cells. The virus has accumulated progressively m...

  • Review
  • Open Access
4 Citations
5,478 Views
16 Pages

Navigating the Challenges of Gluten Enteropathy and Infertility: The Role of Celiac-Related Antibodies and Dietary Changes

  • Monika Peshevska-Sekulovska,
  • Milena Gulinac,
  • Radoslav Rangelov,
  • Desislava Docheva,
  • Tsvetelina Velikova and
  • Metodija Sekulovski

6 December 2023

Celiac disease (CD) is an autoimmune condition that is initiated in genetically susceptible individuals by the exposure of the intestines to gluten, and the early start of symptoms is related to malabsorption. Atypical variants of the illness are oft...

  • Article
  • Open Access
3 Citations
6,663 Views
14 Pages

Prediction of Antibody Viscosity from Dilute Solution Measurements

  • Kamal Bhandari,
  • Yangjie Wei,
  • Brendan R. Amer,
  • Emma M. Pelegri-O’Day,
  • Joon Huh and
  • Jeremy D. Schmit

1 December 2023

The high antibody doses required to achieve a therapeutic effect often necessitate high-concentration products that can lead to challenging viscosity issues in production and delivery. Predicting antibody viscosity in early development can play a piv...

  • Article
  • Open Access
1 Citations
2,809 Views
12 Pages

Factors Associated with SARS-CoV-2 Infection Evaluated by Antibody Response in a Sample of Workers from the Emilia-Romagna Region, Northern Italy

  • Stefania Paduano,
  • Michele Granata,
  • Sara Turchi,
  • Alberto Modenese,
  • Pasquale Galante,
  • Alessandro Poggi,
  • Isabella Marchesi,
  • Giuseppina Frezza,
  • Giulia Dervishaj and
  • Annalisa Bargellini
  • + 4 authors

1 December 2023

Factors associated with SARS-CoV-2 infection risk are still debated. This case–control study aims to investigate the possible relationship between SARS-CoV-2 infection, evaluated through antibody response, and the main sociodemographic, occupat...

  • Article
  • Open Access
5 Citations
3,165 Views
12 Pages

Real-Life Use of Component-Specific IgE in IgE-Mediated Cow’s Milk Protein Allergy in a Spanish Paediatric Allergy Centre

  • Caoimhe Cronin,
  • Cristina Muñoz Archidona,
  • Beatriz Fernández Prudencio,
  • Aoife Gallagher,
  • Roberto Velasco Zuniga and
  • Juan Trujillo Wurttele

17 November 2023

Background: In Spain, IgE-mediated cow’s milk protein allergy (CMPA) affects approximately 0.69% of infants. Molecular diagnosis may be useful for monitoring natural spontaneous tolerance development in CMPA. The aim of this study was to retros...

  • Article
  • Open Access
4 Citations
3,369 Views
12 Pages

Expanding the Anti-Phl p 7 Antibody Toolkit: An Anti-Idiotype Nanobody Inhibitor

  • Susan K. Vester,
  • Anna M. Davies,
  • Rebecca L. Beavil,
  • Balraj S. Sandhar,
  • Andrew J. Beavil,
  • Hannah J. Gould,
  • Brian J. Sutton and
  • James M. McDonnell

16 November 2023

We have previously produced a toolkit of antibodies, comprising recombinant human antibodies of all but one of the human isotypes, directed against the polcalcin family antigen Phl p 7. In this work, we complete the toolkit of human antibody isotypes...

  • Review
  • Open Access
10 Citations
6,074 Views
16 Pages

The Role of Antibody-Based Therapies in Neuro-Oncology

  • Rishab Ramapriyan,
  • Jing Sun,
  • Annabel Curry,
  • Leland G. Richardson,
  • Tarun Ramesh,
  • Matthew A. Gaffey,
  • Patrick C. Gedeon,
  • Elizabeth R. Gerstner,
  • William T. Curry and
  • Bryan D. Choi

13 November 2023

This review explores the evolving landscape of antibody-based therapies in neuro-oncology, in particular, immune checkpoint inhibitors and immunomodulatory antibodies. We discuss their mechanisms of action, blood-brain barrier (BBB) penetration, and...

  • Article
  • Open Access
5 Citations
3,355 Views
16 Pages

New Anti-RSV Nucleoprotein Monoclonal Antibody Pairs Discovered Using Rabbit Phage Display Technology

  • Pierre-Emmanuel Baurand,
  • Jérémy Balland,
  • Emilia Galli,
  • Suvi Eklin,
  • Rémy Bruley and
  • Laurence Ringenbach

8 November 2023

Human respiratory syncytial virus (hRSV) is one of the major contagious viruses and causes complicated respiratory issues, especially in young children. The sensitive and fast detection of hRSV is critical for taking the most effective actions. In th...

  • Review
  • Open Access
23 Citations
10,206 Views
22 Pages

Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy

  • Chi Hun Song,
  • Minchan Jeong,
  • Hyukmin In,
  • Ji Hoe Kim,
  • Chih-Wei Lin and
  • Kyung Ho Han

3 November 2023

In cancer treatment, the first-generation, cytotoxic drugs, though effective against cancer cells, also harmed healthy ones. The second-generation targeted cancer cells precisely to inhibit their growth. Enter the third-generation, consisting of immu...

  • Article
  • Open Access
5 Citations
6,300 Views
14 Pages

Evaluation of Two Chemoenzymatic Glycan Remodeling Approaches to Generate Site-Specific Antibody–Drug Conjugates

  • Qiang Yang,
  • He Chen,
  • Chong Ou,
  • Zhihao Zheng,
  • Xiao Zhang,
  • Yunpeng Liu,
  • Guanghui Zong and
  • Lai-Xi Wang

3 November 2023

Fc-glycosite-specific antibody–drug conjugation represents a promising direction for the preparation of site-specific antibody–drug conjugates (ADCs). In the present research, we conducted a systemic evaluation of two endoglycosidase-cata...

  • Article
  • Open Access
16 Citations
15,090 Views
12 Pages

Elevated IgE Levels—An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections?

  • Polina Kostova,
  • Vera Papochieva,
  • Dimitrinka Miteva,
  • Bilyana Georgieva,
  • Sirma Mileva,
  • Martin Shahid,
  • Tsvetelin Lukanov and
  • Guergana Petrova

3 November 2023

Elevated immunoglobulin E (IgE) is a hallmark of allergic diseases. However, high IgE levels also occur in a number of other infectious and noninfectious diseases. In most cases, elevated IgE levels indicate allergy, eczema, or chronic skin infection...

  • Review
  • Open Access
7 Citations
14,101 Views
13 Pages

31 October 2023

Seronegative rheumatoid arthritis (SNRA) is characterized by the absence of both rheumatoid factor (RF) and antibodies against the cyclic citrullinated protein (ACPA) in serum. However, the differences between the two forms of RA are more complex and...

  • Article
  • Open Access
5 Citations
5,098 Views
22 Pages

Atypical Asparagine Deamidation of NW Motif Significantly Attenuates the Biological Activities of an Antibody Drug Conjugate

  • Mingyan Cao,
  • G. Patrick Hussmann,
  • Yeqing Tao,
  • Ellen O’Connor,
  • Conner Parthemore,
  • Diana Zhang-Hulsey,
  • Dengfeng Liu,
  • Yang Jiao,
  • Niluka de Mel and
  • Xiaoyu Chen
  • + 6 authors

24 October 2023

Asparagine deamidation is a post-translational modification (PTM) that converts asparagine residues into iso-aspartate and/or aspartate. Non-enzymatic asparagine deamidation is observed frequently during the manufacturing, processing, and/or storage...

  • Review
  • Open Access
12 Citations
10,960 Views
24 Pages

Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines

  • Monica L. Fernández-Quintero,
  • Nancy D. Pomarici,
  • Anna-Lena M. Fischer,
  • Valentin J. Hoerschinger,
  • Katharina B. Kroell,
  • Jakob R. Riccabona,
  • Anna S. Kamenik,
  • Johannes R. Loeffler,
  • James A. Ferguson and
  • Andrew B. Ward
  • + 3 authors

18 October 2023

Antibodies and other new antibody-like formats have emerged as one of the most rapidly growing classes of biotherapeutic proteins. Understanding the structural features that drive antibody function and, consequently, their molecular recognition is cr...

  • Article
  • Open Access
9 Citations
4,118 Views
15 Pages

Multiplex Bioanalytical Methods for Comprehensive Characterization and Quantification of the Unique Complementarity-Determining-Region Deamidation of MEDI7247, an Anti-ASCT2 Pyrrolobenzodiazepine Antibody–Drug Conjugate

  • Yue Huang,
  • Jiaqi Yuan,
  • Ruipeng Mu,
  • Robert J. Kubiak,
  • Kathryn Ball,
  • Mingyan Cao,
  • G. Patrick Hussmann,
  • Niluka de Mel,
  • Dengfeng Liu and
  • Anton I. Rosenbaum
  • + 2 authors

17 October 2023

Deamidation, a common post-translational modification, may impact multiple physiochemical properties of a therapeutic protein. MEDI7247, a pyrrolobenzodiazepine (PBD) antibody–drug conjugate (ADC), contains a unique deamidation site, N102, loca...

  • Article
  • Open Access
2 Citations
6,385 Views
26 Pages

Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity

  • Emenike Kenechi Onyido,
  • David James,
  • Jezabel Garcia-Parra,
  • John Sinfield,
  • Anna Moberg,
  • Zoe Coombes,
  • Jenny Worthington,
  • Nicole Williams,
  • Lewis Webb Francis and
  • Deyarina Gonzalez
  • + 1 author

16 October 2023

Antibody–drug conjugates (ADCs) constitute a rapidly expanding category of biopharmaceuticals that are reshaping the landscape of targeted chemotherapy. The meticulous process of selecting therapeutic targets, aided by specific monoclonal antib...

  • Review
  • Open Access
2 Citations
3,847 Views
15 Pages

13 October 2023

The poly-reactivity of antibodies is defined as their binding to specific antigens as well as to related proteins and also to unrelated targets. Poly-reactivity can occur in individual molecules of natural serum antibodies, likely due to their confor...

  • Review
  • Open Access
21 Citations
12,536 Views
20 Pages

Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease

  • Weronika Grąźlewska and
  • Lucyna Holec-Gąsior

5 October 2023

Lyme disease is a tick-borne disease caused by spirochetes belonging to the Borrelia burgdorferi sensu lato complex. The disease is characterized by a varied course; therefore, the basis for diagnosis is laboratory methods. Currently, a two-tiered se...

  • Article
  • Open Access
3,424 Views
12 Pages

26 September 2023

Respiratory Syncytial Virus (RSV) is a significant cause of lower respiratory tract infections in the young, the elderly, and in immunodeficient patients. As such, the virus represents an important cause of morbidity and mortality worldwide. Developm...

  • Article
  • Open Access
4 Citations
3,388 Views
13 Pages

Neutralizing Activity of SARS-CoV-2 Antibodies in Patients with COVID-19 and Vaccinated Individuals

  • Tatjana Vilibic-Cavlek,
  • Vladimir Stevanovic,
  • Snjezana Kovac,
  • Ema Borko,
  • Maja Bogdanic,
  • Gorana Miletic,
  • Zeljka Hruskar,
  • Thomas Ferenc,
  • Ivona Coric and
  • Ljubo Barbic
  • + 3 authors

25 September 2023

Background: Serological diagnosis of COVID-19 is complex due to the emergence of different SARS-CoV-2 variants. Methods: 164 serum samples from (I) patients who recovered from COVID-19 (n = 62) as well as (II) vaccinated individuals (n = 52) and (III...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibodies - ISSN 2073-4468